Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study
Alessio Baricich(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Andrea Santamato(University of Foggia), Stefano Paolucci(Fondazione Santa Lucia), Alessandro Picelli(University of Verona), Stefania Dalise(University of Pisa), Daria Cuneo, Marco Battaglia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Carmelo Chisari(University of Pisa), Marco Invernizzi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Nicoletta Cinone(University of Foggia), Marzia Millevolte(Ospedali Riuniti di Ancona), Stefania Spina(University of Foggia), Mirko Filippetti(University of Verona), Lucia Cosenza(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Lorenza Scotti(University of Milano-Bicocca), Michela Cosma(Arcispedale Sant'Anna), Valentina Azzollini(University of Pisa)
Cited by 19
Related Papers
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial
|BioMed Research International|2017|325
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study
|BMJ|2016|284
Rehabilitation procedures in the management of spasticity.
|PubMed|2010|168